论文部分内容阅读
利美尼定是一种新型的中枢性抗高血压药物,除与α_2-肾上腺素能受体结合外,与咪唑啉受体有更大的亲和力。它通过与咪唑啉受体的结合而发挥降压作用,同时也减轻了与α_2-肾上腺素能受体结合带来的副作用。
Limimetidine is a new central antihypertensive drug that binds to the imidazoline receptor in greater affinity than the alpha 2 -adrenergic receptor. It exerts an antihypertensive effect by binding to the imidazoline receptor, and at the same time alleviates the side effects of binding to the α_2-adrenergic receptor.